Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)

Conditions:   Non-Alcoholic Fatty Liver Disease;   Liver Steatosis Interventions:   Drug: Empagliflozin;   Drug: Dulaglutide;   Drug: Control Rx Sponsors:   National and Kapodistrian University of Athens;   Alexandra Hospital, Athens, Greece;   Hippocration General Hospital Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials